Advertisement

Self-Reported Prevalence of Diabetes Screening in the U.S., 2005–2010

Published:September 15, 2014DOI:https://doi.org/10.1016/j.amepre.2014.07.039

      Background

      Early detection of type 2 diabetes has the potential to prevent complications, but the prevalence of opportunistic screening is unknown.

      Purpose

      To describe the prevalence of diabetes screening by demographic and diabetes-related factors and to determine predictors of screening among a representative U.S. population without self-reported diabetes.

      Methods

      Cross-sectional data were obtained from the 2005–2010 National Health and Nutrition Examination Survey (n=15,125) and 2006 National Health Interview Survey (n=21,519). Participants were aged ≥20 years and self-reported having a diabetes screening test in the past 3 years. Diabetes screening prevalence was analyzed according to risk factors recommended by the American Diabetes Association. Logistic regression was used to determine significant predictors of diabetes screening. Analysis was conducted in 2012–2013.

      Results

      The prevalence of having a blood test for diabetes in the past 3 years was 42.1% in 2005–2006, 41.6% in 2007–2008, and 46.8% in 2009–2010. This prevalence increased with age and was higher for women, non-Hispanic whites, and those with more education and income (p<0.001 for all). BMI ≥25, age ≥45 years, having a relative with diabetes, hypertension, glycosylated hemoglobin ≥5.7%, and cardiovascular disease history were significant predictors of screening. For each additional risk factor, the likelihood of screening increased by 51%.

      Conclusions

      Nearly half of the adult population reported having a diabetes screening test. However, testing was less prevalent in minorities and those with lower socioeconomic status. Public health efforts to address these deficiencies in screening are needed.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cheng Y.J.
        • Imperatore G.
        • Geiss L.S.
        • et al.
        Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010.
        Diabetes Care. 2013; 36: 2690-2696
        • CDC.
        National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011.
        USDHHS, CDC, Atlanta GA2011
        • Stamler J.
        • Vaccaro O.
        • Neaton J.D.
        • Wentworth D.
        Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.
        Diabetes Care. 1993; 16: 434-444
        • Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group.
        European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe.
        Lancet. 1999; 354: 617-621
        • Khaw K.T.
        • Wareham N.
        • Bingham S.
        • Luben R.
        • Welch A.
        • Day N.
        Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
        Ann Intern Med. 2004; 141: 413-420
        • Laakso M.
        Hyperglycemia and cardiovascular disease in type 2 diabetes.
        Diabetes. 1999; 48: 937-942
        • American Diabetes Association
        Standards of medical care in diabetes—2013.
        Diabetes Care. 2013; 36: S11-S66
      1. CDC. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey. Hyattsville MD: USDHHS, CDC, 2005–2010.

      2. NHIS Survey Description. Hyattsville MD: USDHHS, CDC, 2006.

        • CDC. National Center for Health Statistics (NCHS).
        National Health and Nutrition Examination Survey Laboratory Protocol.
        USDHHS, CDC, Hyattsville MD2008
        • CDC.
        National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States 2011.
        USDHHS, CDC, Atlanta GA2011
        • Knowler W.C.
        • Barrett-Connor E.
        • Fowler S.E.
        • et al.
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        • Orchard T.J.
        • Temprosa M.
        • Barrett-Connor E.
        • et al.
        Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study.
        Diabet Med. 2013; 30: 46-55
        • Griffin S.J.
        • Borch-Johnsen K.
        • Davies M.J.
        • et al.
        Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.
        Lancet. 2011; 378: 156-167
        • Flegal K.M.
        • Carroll M.D.
        • Kit B.K.
        • Ogden C.L.
        Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
        JAMA. 2012; 307: 491-497
        • Ogden C.L.
        • Carroll M.D.
        • Kit B.K.
        • Flegal K.M.
        Prevalence of obesity in the United States, 2009-2010.
        NCHS Data Brief. 2012; 82: 1-8
        • Cowie C.C.
        • Rust K.F.
        • Byrd-Holt D.D.
        • et al.
        Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006.
        Diabetes Care. 2010; 33: 562-568
        • International Expert Committee.
        International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.
        Diabetes Care. 2009; 32: 1327-1334
        • American Diabetes Association
        Standards of medical care in diabetes—2010.
        Diabetes Care. 2010; 33: S11-S61
        • Casagrande S.S.
        • Cowie C.C.
        • Fradkin J.E.
        Utility of the U.S. Preventive Services Task Force criteria for diabetes screening.
        Am J Prev Med. 2013; 45: 167-174